You can now read 10 articles a month for free. Read as much as you want anywhere and anytime for just 99¢.

Abiomed stock falls 31 percent after the Danvers company says it’s under federal investigation

Shares of Abiomed Inc. plunged by nearly one-third on the Nasdaq stock exchange Thursday after the Danvers company said it is the subject of a federal investigation.

In documents filed with the Securities and Exchange Commission, the cardiac device maker disclosed it has received a subpoena from the US attorney’s office seeking files related to the labeling and marketing of its Impella 2.5 heart pump.

Continue reading below

“We are in the process of responding to the subpoena and intend to cooperate fully,” Abiomed said in the filing.

Abiomed’s shares closed Thursday at $13.61, down $6.21, or 31.33 percent, on the Nasdaq.

Robert Weisman can be reached at weisman@globe.com.
Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week